Skip to main content

Microsoft and a Seattle biotech are seeking 1,000 volunteers to give blood for a virtual coronavirus study. Here's how you can enroll and make up to $250.

* The technology giant Microsoft is working with a Seattle-based biotech to better understand the wide range of immune responses to the novel coronaviruses.  * The duo are recruiting 1,000 US-based volunteers to enroll in a virtual trial. Eligible people have to live near certain metro areas and have to have been exposed to the virus, infected with it, or recently recovered from it. * Applying for the study can be done completely online by answering some basic questions. Selected participants will have their blood drawn at their home. * The data could help better understand some of the mysteries around the coronavirus, particularly why some people have barely any symptoms while others end up critically ill.  * Visit Business Insider's homepage for more stories. A new study is aiming to help figure out why the coronavirus affects people in such drastically different ways.  Some infected people have no symptoms, while others wind up critically ill and requiring weeks of oxygen support in a hospital. The tech giant Microsoft has launched a study with the Seattle-based biotech Adaptive Biotechnologies to better understand the wide range of immune responses to the virus.  The two companies are recruiting 1,000 volunteers for a virtual study. Eligible participants have to be located in one of about two dozen metro areas across the US, and to have been exposed to, infected with, or recovered from the novel coronavirus.  Read more: Microsoft is teaming up with a $5 billion Seattle biotech to unravel the mystery of how the immune system responds to the coronavirus, and it could lead to new treatments and tests The researchers are specifically focusing on T-cell responses, which are a critical element of the body's immune response. T cells help fight the virus, and long-lasting cells may help build immunity to future infections.  Following the explosion of antibody tests and research, Microsoft and Adaptive are hoping this research can build a "third pillar" of COVID-19 testing focused on T cells, said Lance Baldo, Adaptive's chief medical officer.  Enrollment is open now and is done online The study is open to people living within 60 miles of 23 different metro areas across the US, including Los Angeles, Boston, New York, and Houston.   The study has already enrolled more than 100 people across the three eligible groups of exposed, infected, and recovered people. To qualify for the exposed group, you need to either live with someone that has a confirmed case of COVID-19 or be a healthcare worker treating sickened patients without protective gear.  Infected COVID-19 patients are required to have a confirmed diagnosis, either through a positive test result or a diagnosis from a healthcare provider. Never miss out on healthcare news. Subscribe to Dispensed, Business Insider's weekly newsletter on pharma, biotech, and healthcare. People meeting those criteria can enroll online by filling out a questionnaire. If selected, researchers will arrange for a phlebotomist to come to you to draw blood samples. The technician will be wearing protective equipment and will also conduct or throat or nasal swab.  The study is offering $50 gift cards to those who complete the initial study. Researchers are also giving participants the option to participate in up to four additional blood draws over a two-month period. Participants completing all five blood draws could earn $250 in gift cards.  While the money may be a nice incentive, the research could help decode some of the mysteries about the coronavirus. Microsoft and Adaptive have pledged to make the data and findings freely available.  Initial results could come as soon as June, Adaptive's Baldo said. For more information, go to immunerace.com.  Join the conversation about this story » NOW WATCH: How the Navy's largest hospital ship can help with the coronavirus
https://bit.ly/2LoA0we

Popular posts from this blog

Tokyo installed see-through public toilets in a park to let people inspect their cleanliness before using them, at which point the glass turns opaque

* Two see-through bathrooms have been installed in public parks in Tokyo. * They are made from "smart glass" designed so people can see how clean they are inside before using them. The glass turns opaque when the bathroom is locked and in use. * The stalls are part of a project that is redoing 17 of the city's public bathrooms with different designers to make them more accessible and appealing. * The goal is to fight assumptions that public toilets are "are dark, dirty, smelly, and scary," said the nonprofit foundation behind the project. * Visit Business Insider's homepage for more stories. Tokyo has installed two see-through bathroom facilities in public parks, allowing people to see how clean they are before deciding to use them, at which point they turn opaque. The bathrooms are made of colored "smart glass," which turns opaque when the stalls are locked, said Shigeru Ban, the architect behind the designs. You can see how it works her...
Read more

Bill Gates says the world would need as many as 14 billion doses of a coronavirus vaccine to stop the virus

* The world could need as many as 14 billion doses of COVID-19 vaccines, Bill Gates said on Thursday in a blog post about the race to develop a way to make people immune to the disease. * "We need to make billions of doses, we need to get them out to every part of the world, and we need all of this to happen as quickly as possible," Gates said. * Gates said he had his eyes on eight to 10 promising candidates, adding that healthcare workers and people in low-income countries should be first in line once we find one that works. * While potential vaccines are progressing with historic speed, they're still months, or even years away, and the biggest challenge lies ahead in proving whether they are safe and effective in humans. * Visit Business Insider's homepage for more stories. Bill Gates believes we may eventually need to produce as many as 14 billion doses of COVID-19 vaccines globally and that we're anywhere from nine months to two years away from making tha...
Read more

The 11 most important details we already know about the PlayStation 5, Sony's next-generation video game console set to arrive this year

* The PlayStation 5, Sony's next-generation game console that's deep in production, is scheduled to launch during the 2020 holiday season. * As you might expect, the PlayStation 5 is promised to be more powerful than the existing PlayStation 4 — and we've slowly been learning more about the next-gen console's new features since it was first revealed. * So far, Sony has offered a first glimpse at the new console via its new DualSense gamepad, and a tech demo highlighted the technical prowess of the new machine. * Here's everything we know so far about Sony's next-generation PlayStation console. * Visit Business Insider's homepage for more stories. The PlayStation 5 is almost here. Sony's next-generation PlayStation game console is scheduled to arrive this holiday season, but we already know plenty of details about it right now: how powerful it is, its main features, and we've even gotten a good look at its new gamepad.  Here everything we kno...
Read more